Table 3.
Models | Baseline hormone | Change in hormone from baseline | ||
---|---|---|---|---|
Risk Ratio (95% CI) | P Value | Risk Ratio (95% CI) | P Value | |
Model 1: E2 | 0.85 (0.69 - 1.05) | 0.13 | 0.90 (0.73 - 1.11) | 0.32 |
Model 2: T | 2.04 (1.45 - 2.86) | <0.001 | 1.28 (0.81 - 2.02) | 0.29 |
Model 3: SHBG | 0.58 (0.48 - 0.70) | <0.001 | 0.80 (0.58 - 1.10) | 0.20 |
Model4: FAI | 1.77 (1.50 - 2.09) | <0.001 | 1.22 (0.93 - 1.60) | 0.16 |
Model 5: RAE | 1.41 (1.17 - 1.69) ‡ | 0.001 | 1.24 (1.01 - 1.52) | 0.04 |
All models were adjusted for ethnicity, age at baseline, residual BMI, ‘phlebotomy in window’, site, physical activity, level of education.
Relative Androgen Excess baseline value is the T/E2 molar ratio at study entry.